Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aasen, 2008, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes, Nat. Biotechnol, 26, 1276, 10.1038/nbt.1503
Adewumi, 2007, Characterization of human embryonic stem cell lines by the International Stem Cell Initiative, Nat. Biotechnol, 25, 803, 10.1038/nbt1318
Amenduni, 2011, iPS cells to model CDKL5-related disorders, Eur. J. Hum. Genet, 19, 1246, 10.1038/ejhg.2011
Asai, 2010, Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development, Curr. Stem Cell Res. Ther, 5, 227, 10.2174/157488810791824502
Bahadduri, 2010, Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo, Methods Mol. Biol, 637, 65, 10.1007/978-1-60761-700-6_4
Batista, 2011, Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells, Nature, 474, 399, 10.1038/nature10084
Brambrink, 2008, Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells, Cell Stem Cell, 2, 151, 10.1016/j.stem.2008.01.004
Briggs, 2013, Concise review: new paradigms for down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease, Stem Cells Transl. Med, 2, 175, 10.5966/sctm.2012-0117
Campuzano, 1996, Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion, Science, 271, 1423, 10.1126/science.271.5254.1423
Cao, 2008, Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes, PLoS ONE, 3, e3474, 10.1371/journal.pone.0003474
Carvajal-Vergara, 2010, Patient-specifi c induced pluripotent stem-cell derived models of LEOPARD syndrome, Nature, 465, 808, 10.1038/nature09005
Cheng, 2013, Rab25 small GTPase mediates secretion of tumor necrosis factor receptor superfamily member 11b (osteoprotegerin) protecting cancer cells from effects of TRAIL, J. Genet. Syndr. Gene Ther, 4, 153, 10.4172/2157-7412.1000153
Chestkov, 2014, Patient-specific induced pluripotent stem cells for SOD1-associated amyotrophic lateral sclerosis pathogenesis studies, Acta Naturae, 6, 54, 10.32607/20758251-2014-6-1-54-60
Choi, 2013, Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells, Hepatology, 57, 2458, 10.1002/hep.26237
Chun, 2011, Induced pluripotent stem cells and personalized medicine: current progress and future perspectives, Anat. Cell Biol, 44, 245, 10.5115/acb.2011.44.4.245
Desnuelle, 2001, A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group, Amyotroph. Lateral Scler. Other Motor Neuron Disord, 2, 9, 10.1080/146608201300079364
Devine, 2011, Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus, Nat. Commun, 2, 440, 10.1038/ncomms1453
Dimos, 2008, Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons, Science, 321, 1218, 10.1126/science.1158799
Doherty, 2003, Microcell-mediated chromosome transfer (MMCT): small cells with huge potential, Mamm. Genome, 14, 583, 10.1007/s00335-003-4002-0
Ebert, 2009, Induced pluripotent stem cells from a spinal muscular atrophy patient, Nature, 457, 277, 10.1038/nature07677
Evans, 1981, Establishment in culture of pluripotential cells from mouse embryos, Nature, 292, 154, 10.1038/292154a0
Farra, 2012, Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations, Mol. Psychiatry, 17, 1261, 10.1038/mp.2011.180
Feng, 2009, Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb, Nat. Cell Biol, 11, 197, 10.1038/ncb1827
Filareto, 2013, An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells, Nat. Commun, 4, 1549, 10.1038/ncomms2550
Fong, 2013, Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells, Stem Cell Reports, 1, 226, 10.1016/j.stemcr.2013.08.001
Fong, 2011, A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells, Cell, 147, 120, 10.1016/j.cell.2011.08.038
Fusaki, 2009, Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, Proc. Jpn. Acad. Ser. B Phys. Biol. Sci, 85, 348, 10.2183/pjab.85.348
Gangopadhyay, 1992, Dystrophin in frameshift deletion patients with Becker muscular dystrophy, Am. J. Hum. Genet, 51, 562
Ghaleb, 2005, Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation, Cell Res, 15, 92, 10.1038/sj.cr.7290271
Gonzalez, 2009, Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector, Proc. Natl. Acad. Sci. U.S.A, 106, 8918, 10.1073/pnas.0901471106
Grizot, 2009, Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease, Nucleic Acids Res, 37, 5405, 10.1093/nar/gkp548
Groeneveld, 2003, A randomized sequential trial of creatine in amyotrophic lateral sclerosis, Ann. Neurol, 53, 437, 10.1002/ana.10554
Guha, 2013, Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells, Cell Stem Cell, 12, 407, 10.1016/j.stem.2013.01.006
Gunaseeli, 2010, Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery, Curr. Med. Chem, 17, 759, 10.2174/092986710790514480
Gurdon, 1962, The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles, J. Embryol. Exp. Morphol, 10, 622
Haase, 2009, Generation of induced pluripotent stem cells from human cord blood, Cell Stem Cell, 5, 434, 10.1016/j.stem.2009.08.021
Hanna, 2008, Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency, Cell, 133, 250, 10.1016/j.cell.2008.03.028
Hochedlinger, 2002, Nuclear transplantation: lessons from frogs and mice, Curr. Opin. Cell Biol, 14, 741, 10.1016/S0955-0674(02)00380-0
Hochedlinger, 2005, Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues, Cell, 121, 465, 10.1016/j.cell.2005.02.018
Hockemeyer, 2009, Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases, Nat. Biotechnol, 27, 851, 10.1038/nbt.1562
Hockemeyer, 2011, Genetic engineering of human pluripotent cells using TALE nucleases, Nat. Biotechnol, 29, 731, 10.1038/nbt.1927
Howe, 2008, Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients, J. Clin. Invest, 118, 3143, 10.1172/JCI35798
Huangfu, 2008a, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol, 26, 795, 10.1038/nbt1418
Huangfu, 2008b, Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2, Nat. Biotechnol, 26, 1269, 10.1038/nbt.1502
Hurtado-Lorenzo, 2004, Differentiation and transcription factor gene therapy in experimental Parkinson's disease: sonic hedgehog and Gli-1, but Not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration, Mol. Ther, 10, 507, 10.1016/j.ymthe.2004.05.021
Israel, 2012, Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells, Nature, 482, 216, 10.1038/nature10821
Jiang, 2012, Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease, Stem Cells, 30, 599, 10.1002/stem.1053
Kaitin, 2008, Obstacles and opportunities in new drug development, Clin. Pharmacol. Ther, 83, 210, 10.1038/sj.clpt.6100462
Kaye, 2013, Modeling Huntington's disease with induced pluripotent stem cells, Mol. Cell. Neurosci, 56, 50, 10.1016/j.mcn.2013.02.005
Kazuki, 2009, Complete genetic correction of iPS cells from Duchenne muscular dystrophy, Am. Soc. Gene Cell Ther, 18, 386, 10.1038/mt.2009.274
Kerns, 1983, Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure, Cancer Res, 43, 4382
Khan, 2010, Engineering of human pluripotent stem cells by AAV-mediated gene targeting, Mol. Ther, 18, 1192, 10.1038/mt.2010.55
Kim, 2009b, Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, Cell Stem Cell, 4, 472, 10.1016/j.stem.2009.05.005
Kim, 2009a, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 649, 10.1038/nature08436
Kimmel, 1983, Correlating pharmacokinetics and teratogenic endpoints, Fundam. Appl. Toxicol, 3, 250, 10.1016/S0272-0590(83)80136-5
Klein, 2003, Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice, Blood, 101, 2159, 10.1182/blood-2002-05-1423
Ku, 2010, Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA•TTC triplet repeat instability, Cell Stem Cell, 7, 631, 10.1016/j.stem.2010.09.014
Kunisato, 2011, Direct generation of induced pluripotent stem cells from human nonmobilized blood, Stem Cells Dev, 20, 159, 10.1089/scd.2010.0063
Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nat. Biotechnol, 25, 1015, 10.1038/nbt1327
Lan, 2012, Characterizing the radioresponse of pluripotent and multipotent human stem cells, PLoS ONE, 7, e50048, 10.1371/journal.pone.0050048
Laustriat, 2010, Human pluripotent stem cells in drug discovery and predictive toxicology, Biochem. Soc. Trans, 38, 1051, 10.1042/BST0381051
Lee, 2009, Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs, Nature, 461, 402, 10.1038/nature08320
Lee, 2011, Modelling familial dysautonomia in human induced pluripotent stem cells, Phil. Trans. R. Soc. B, 366, 2286, 10.1098/rstb.2011.0026
Lei, 1995, Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus, Am. J. Hum. Genet, 57, 766
Levenberg, 2010, Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells, Nat. Protoc, 5, 1115, 10.1038/nprot.2010.31
Lim, 2013, Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells, Stem Cell Res. Ther, 4, 71, 10.1186/scrt222
Li, 2009, Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors, Cell Stem Cell, 4, 16, 10.1016/j.stem.2008.11.014
Li, 2012, Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa, Mol. Med, 18, 1312, 10.2119/molmed.2012.00242
Li, 2011, Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules, Cell Res, 21, 196, 10.1038/cr.2010.142
Liu, 2011a, Recapitulation of premature ageing with iPSCs from Hutchinson–Gilford progeria syndrome, Nature, 472, 221, 10.1038/nature09879
Liu, 2011b, In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins, Sci. Transl. Med, 3, 82ra39, 10.1126/scitranslmed.3002376
Liu, 2010, Generation of endoderm derived human ips cells from primary hepatocytes, Hepatology, 51, 1810, 10.1002/hep.23626
Maherali, 2008, A high-efficiency system for the generation and study of human induced pluripotent stem cells, Cell Stem Cell, 3, 340, 10.1016/j.stem.2008.08.003
Mali, 2008, Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts, Stem Cells, 26, 1998, 10.1634/stemcells.2008-0346
Marson, 2008, Wnt signaling promotes reprogramming of somatic cells to pluripotency, Cell Stem Cell, 3, 132, 10.1016/j.stem.2008.06.019
McNeish, 2010, High throughput screening in embryonic stem cell derived neurons identifies potentiators of a-amino-3-hydroxyl-5-methyl-4- isoxazolepropionate-type glutamate receptors, J. Biol. Chem, 285, 17209, 10.1074/jbc.M109.098814
Mikkelsen, 2008, Dissecting direct reprogramming through integrative genomic analysis, Nature, 454, 49, 10.1038/nature07056
Moad, 2013, A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells, Eur. Urol, 64, 753, 10.1016/j.eururo.2013.03.054
Nguyen, 2011, LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress, Cell Stem Cell, 8, 267, 10.1016/j.stem.2011.01.013
Nori, 2011, Human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice, Proc. Natl. Acad. Sci. U.S.A, 108, 16825, 10.1073/pnas.1108077108
Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934
Okita, 2008, Generation of mouse induced pluripotent stem cells without viral vectors, Science, 322, 949, 10.1126/science.1164270
Pappas, 2008, Human ESC vs. iPSC- Pros and Cons, J. Cardiovasc. Trans. Res, 1, 96, 10.1007/s12265-008-9032-2
Park, 2008c, Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions, Int. J. Cancer, 122, 1253, 10.1002/ijc.23225
Park, 2008b, Disease-specific induced pluripotent stem cells, Cell, 134, 877, 10.1016/j.cell.2008.07.041
Park, 2008a, Reprogramming of human somatic cells to pluripotency with defined factors, Nature, 451, 141, 10.1038/nature06534
Rashid, 2010, Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J. Clin. Invest, 120, 3127, 10.1172/JCI43122
Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0
Ruiz, 2010, High-efficient generation of induced pluripotent stem cells from human astrocytes, PLoS ONE, 5, e15526, 10.1371/journal.pone.0015526
Sato, 2004, How does Fgf signaling from the isthmic organizer induce midbrain and cerebellum development?, Dev. Growth Differ, 46, 487, 10.1111/j.1440-169x.2004.00769.x
Sauer, 2012, Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy, J. Clin. Invest, 122, 2141, 10.1172/JCI61788
Seiler, 2004, Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test, Reprod. Toxicol, 18, 231, 10.1016/j.reprotox.2003.10.015
Seki, 2010, Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells, Cell Stem Cell, 7, 11, 10.1016/j.stem.2010.06.003
Shefner, 2004, NEALS Consortium. A clinical trial of creatine in ALS, Neurology, 63, 1656, 10.1212/01.WNL.0000142992.81995.F0
Shi, 2008a, Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds, Cell Stem Cell, 3, 568, 10.1016/j.stem.2008.10.004
Shi, 2008b, A combined chemical and genetic approach for the generation of induced pluripotent stem cells, Cell Stem Cell, 2, 525, 10.1016/j.stem.2008.05.011
Silva, 2008, Promotion of reprogramming to ground state pluripotency by signal inhibition, PLoS Biol, 6, e253, 10.1371/journal.pbio.0060253
Soejitno, 2011, The prospect of induced pluripotent stem cells for diabetes mellitus treatment, Ther. Adv. Endocrinol. Metab, 2, 197, 10.1177/2042018811420198
Soldner, 2009, Parkinson's disease patient derived induced pluripotent stem cells free of viral reprogramming factors, Cell, 136, 964, 10.1016/j.cell.2009.02.013
Sollano, 2008, The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace, Clin. Pharmacol. Ther, 84, 263, 10.1038/clpt.2008.117
Somers, 2010, Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette, Stem Cells, 28, 1728, 10.1002/stem.495
Song, 2011, Generation of induced pluripotent stem cells from human kidney mesangial cells, J. Am. Soc. Nephrol, 22, 1213, 10.1681/ASN.2010101022
Stadtfeld, 2008a, Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse, Cell Stem Cell, 2, 230, 10.1016/j.stem.2008.02.001
Stadtfeld, 2008b, Induced pluripotent stem cells generated without viral integration, Science, 322, 945, 10.1126/science.1162494
Sugii, 2010, Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells, Proc. Natl. Acad. Sci. U.S.A, 107, 3558, 10.1073/pnas.0910172106
Sullivan, 2010, Generation of functional human hepatic endoderm from human induced pluripotent stem cells, Hepatology, 51, 329, 10.1002/hep.23335
Suzuki, 2008, Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors, Proc. Natl. Acad. Sci. U.S.A, 105, 13781, 10.1073/pnas.0806976105
Suzuki, 2013, Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation, Mol. Ther, 21, 1424, 10.1038/mt.2013.71
Tada, 2001, Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells, Curr. Biol, 11, 1553, 10.1016/S0960-9822(01)00459-6
Takahashi, 2006b, Identification of genes involved in tumor-like properties of embryonic stem cells, Methods Mol. Biol, 329, 449, 10.1385/1-59745-037-5:449
Takahashi, 2006a, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024
Tan, 2012, Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering, Tissue Eng. Part A, 18, 840, 10.1089/ten.tea.2011.0362
Tanaka, 2009, In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes, Biochem. Biophys. Res. Commun, 385, 497, 10.1016/j.bbrc.2009.05.073
Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145
Till, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat. Res, 14, 213, 10.2307/3570892
Tulpule, 2013, Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction, Cell Stem Cell, 12, 727, 10.1016/j.stem.2013.04.002
Utikal, 2009, Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells, J. Cell Sci, 122, 3502, 10.1242/jcs.054783
Wang, 2012, The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis, Stem Cell Res. Ther, 3, 39, 10.1186/scrt130
Warren, 2010, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, 7, 618, 10.1016/j.stem.2010.08.012
Wilmut, 1997, Viable offspring derived from fetal and adult mammalian cells, Nature, 385, 810, 10.1038/385810a0
Wobus, 2011, Present state and future perspectives of using pluripotent stem cells in toxicology research, Arch. Toxicol, 85, 79, 10.1007/s00204-010-0641-6
Woltjen, 2009, piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells, Nature, 458, 766, 10.1038/nature07863
Xu, 2009, Phenotypic correction of murine hemophilia A using an iPS cell-based therapy, Proc. Natl. Acad. Sci. U.S.A, 106, 808, 10.1073/pnas.0812090106
Yazawa, 2011, Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome, Nature, 471, 230, 10.1038/nature09855
Ye, 2009, Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders, Blood, 114, 5473, 10.1182/blood-2009-04-217406
Yokoo, 2009, The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells, Biochem. Biophys. Res. Commun, 387, 482, 10.1016/j.bbrc.2009.07.052
Yoshida, 2014, The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa, Mol. Brain, 7, 45, 10.1186/1756-6606-7-45
Yoshida, 2010, Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration, Circulation, 122, 80, 10.1161/CIRCULATIONAHA.109.881433
Yoshioka, 2013, Efficient generation of human iPSCs by a synthetic self-replicative RNA, Cell Stem Cell, 13, 246, 10.1016/j.stem.2013.06.001
Yu, 2009, Human induced pluripotent stem cells free of vector and transgene sequences, Science, 324, 797, 10.1126/science.1172482
Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526
Yusa, 2009, Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon, Nat. Methods, 6, 363, 10.1038/nmeth.1323
Zhang, 2012, Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy, Stem Cells Dev, 21, 955, 10.1089/scd.2011.0649
Zhang, 2013, Induced pluripotent stem cells are sensitive to DNA damage, Genomics Proteomics Bioinformatics, 11, 320, 10.1016/j.gpb.2013.09.006
Zhao, 2008, Two supporting factors greatly improve the efficiency of human iPSC generation, Cell Stem Cell, 3, 475, 10.1016/j.stem.2008.10.002
Zhou, 2008, In vivo reprogramming of adult pancreatic exocrine cells to β-cells, Nature, 455, 627, 10.1038/nature07314